ArticleCancers2019

Simultaneous Inhibition of BCR-ABL1 Tyrosine Kinase and PAK1/2 Serine/Threonine Kinase Exerts Synergistic Effect against Chronic Myeloid Leukemia Cells.

Sylwia Flis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.